In addition, BXL0124, a Gemini vitamin D analog, was evaluated in basal-like breast cancer cells, resulting in decreased CD44+/CD24−/low population by inhibiting Notch1 signaling [99]. This evidence concerns the gene CD44 and breast carcinoma.